{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20161228",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20160412",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20150513",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20150429",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "19676",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205718s002lbl.pdf",
              "date": "20150506",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20141010",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1/4",
          "submission_class_code_description": "Type 1 - New Molecular Entity and Type 4 - New Combination",
          "application_docs": [
            {
              "id": "19675",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205718s000lbl.pdf",
              "date": "20141014",
              "type": "Label"
            },
            {
              "id": "23000",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205718Orig1s000TOC.html",
              "date": "20141107",
              "type": "Review"
            },
            {
              "id": "24502",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205718Orig1s000SumR.pdf",
              "date": "20141107",
              "type": "Summary Review"
            },
            {
              "id": "32709",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205718Orig1s000ltr.pdf",
              "date": "20141010",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20210602",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "67686",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205718s009lbl.pdf",
              "date": "20210603",
              "type": "Label"
            },
            {
              "id": "67691",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205718Orig1s009ltr.pdf",
              "date": "20210603",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20150720",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20150427",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "19677",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205718Orig1s003lbl.pdf",
              "date": "20150504",
              "type": "Label"
            },
            {
              "id": "32710",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205718Orig1s003ltr.pdf",
              "date": "20150429",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150216",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        }
      ],
      "application_number": "NDA205718",
      "sponsor_name": "HELSINN HLTHCARE",
      "openfda": {
        "application_number": [
          "NDA205718"
        ],
        "brand_name": [
          "AKYNZEO"
        ],
        "generic_name": [
          "NETUPITANT AND PALONOSETRON"
        ],
        "manufacturer_name": [
          "Helsinn Therapeutics (U.S.), Inc."
        ],
        "product_ndc": [
          "69639-101",
          "69639-102",
          "69639-105",
          "69639-106"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "NETUPITANT",
          "PALONOSETRON"
        ],
        "rxcui": [
          "1552343",
          "1552349",
          "2044429",
          "2044431",
          "2374366",
          "2374368"
        ],
        "spl_id": [
          "4a6ba486-f8be-41a3-847e-429548867605"
        ],
        "spl_set_id": [
          "8e47618e-af46-4d82-94e8-1507c042252d"
        ],
        "package_ndc": [
          "69639-101-01",
          "69639-101-04",
          "69639-102-01",
          "69639-105-01",
          "69639-106-01"
        ],
        "nui": [
          "N0000175817",
          "N0000175818",
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_moa": [
          "Serotonin 3 Receptor Antagonists [MoA]",
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Serotonin-3 Receptor Antagonist [EPC]",
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "T672P80L2S",
          "5D06587D6R",
          "23310D4I19",
          "7732P08TIR"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "AKYNZEO",
          "active_ingredients": [
            {
              "name": "NETUPITANT",
              "strength": "300MG"
            },
            {
              "name": "PALONOSETRON HYDROCHLORIDE",
              "strength": "EQ 0.5MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}